Royal Bank Of Canada Taro Pharmaceutical Industries LTD Transaction History

Royal Bank Of Canada

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Nov 05, 2024	BUY	$40.97 - $43.33 $7,497 - $7,929	183 New	183 $7,000
Q1 2024 May 15, 2024	SELL	$40.97 - $43.33 $73,746 - $77,994	-1,800 Reduced 90.77%	183 $7,000
Q4 2023 Feb 14, 2024	SELL	$32.77 - $42.31 $1,409 - $1,819	-43 Reduced 2.12%	1,983 $82,000
Q3 2023 Nov 14, 2023	BUY	$35.46 - $40.13 $34,999 - $39,608	987 Added 95.0%	2,026 $76,000
Q2 2023 Aug 14, 2023	BUY	$24.24 - $40.97 $21,888 - $36,995	903 Added 663.97%	1,039 $39,000
Q1 2023 May 15, 2023	BUY	$23.0 - $31.59 $3,059 - $4,201	133 Added 4433.33%	136 $3,000
Q4 2022 Feb 14, 2023	BUY	$27.6 - $32.99 $55 - $65	2 Added 200.0%	3 $0
Q3 2022 Nov 14, 2022	SELL	$28.74 - $39.9 $14,370 - $19,950	-500 Reduced 99.8%	1 $0
Q2 2022 Aug 15, 2022	SELL	$35.0 - $43.59 $1,540 - $1,917	-44 Reduced 8.07%	501 $18,000
Q1 2022 May 16, 2022	BUY	$43.12 - $50.3 $1,207 - $1,408	28 Added 5.42%	545 $24,000
Q4 2021 Feb 14, 2022	SELL	$47.6 - $65.0 $2 Million - $2.73 Million	-41,926 Reduced 98.78%	517 $26,000
Q3 2021 Nov 15, 2021	SELL	$62.34 - $73.38 $3.07 Million - $3.61 Million	-49,226 Reduced 53.7%	42,443 $2.7 Million
Q2 2021 Aug 16, 2021	BUY	$70.26 - $76.64 $6.44 Million - $7.03 Million	91,669 New	91,669 $6.6 Million

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.